# US 2012/0252760 A1 · Novel pyridopyrazines and their use as modulators of kinases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252760 A1
- Document ID: US20120252760A1
- Status: Published application
- Kind: A1
- Application number: 13/523,968
- Filed: 2012-06-15
- Published: 2012-10-04
- Earliest claimed: 2005-11-11
- Assignees: Zentaris AG
- Inventors: Eckhard Claus; Irene Seipelt; Eckhard Guenther; Emmanuel Polymeropoulos; Michael Czech; Tilmann Schuster
- Web page: https://patentgrep.com/patent/US20120252760A1

## CPC

- A61K 31/4985: Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 31/675: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61K 31/695: Silicon compounds
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 17/06: Antipsoriatics
- C07D 487/04: Ortho-condensed systems
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention relates to novel pyrido[2,3-b]pyrazine derivatives of the general formulae (I) and (II), and to their preparation and use as medicaments, especially for the treatment of malignant disorders and other disorders based on pathological cell proliferations.

## Claims

### Claim at position 1

1-64. (canceled)

### Claim 65

A pyrido[2,3-b]pyrazine compound of the Formula I
wherein:
R2 and R4: hydrogen
R1 is substituted heteroaryl, wherein the heteroaryl has one or more, identical or different, substituents selected from the group consisting of
(i) NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, NH-alkyl-NH2, NH-alkyl-OH, N(alkyl)2, NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO2-alkyl, NHSO2-cycloalkyl, NHSO2-heterocyclyl, NHSO2-aryl, NHSO2-heteroaryl, NHSO2-alkyl-aryl, NHSO2-alkyl-heteroaryl, S-alkyl, S-aryl, S-heteroaryl, O-alkyl, O-cycloalkyl, O-aryl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO2-alkyl, OSO2-cycloalkyl, OSO2-heterocyclyl, OSO2-aryl, OSO2-heteroaryl, OSO2-alkyl-aryl, OSO2-alkyl-heteroaryl, C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO2-alkyl, CO2-cycloalkyl, CO2-heterocyclyl, CO2-aryl, CO2-heteroaryl, CO2-alkyl-cycloalkyl, CO2-alkyl-heterocyclyl, CO2-alkyl-aryl, CO2-alkyl-heteroaryl, C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl)2, C(O)N(cycloalkyl)2, C(O)N(aryl)2, C(O)N(heteroaryl)2, SO2NH-alkyl, SO2NH-aryl, SO2NH-heteroaryl, SO2NH-alkyl-aryl, SO2O-alkyl, SO2O-aryl, SO2O-alkyl-aryl, alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl,
wherein the alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl substituents of (i) optionally include one or more, identical or different, substituents selected from the group consisting of
(ii) NH-cycloalkyl, NH-heterocyclyl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, NH-alkyl-NH2, NH-alkyl-OH, NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO2-alkyl, NHSO2-cycloalkyl, NHSO2-heterocyclyl, NHSO2-aryl, NHSO2-heteroaryl, NHSO2-alkyl-aryl, NHSO2-alkyl-heteroaryl, S-aryl, S-heteroaryl, O-cycloalkyl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO2-alkyl, OSO2-cycloalkyl, OSO2-heterocyclyl, OSO2-aryl, OSO2-heteroaryl, OSO2-alkyl-aryl, OSO2-alkyl-heteroaryl, C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO2-alkyl, CO2-cycloalkyl, CO2-heterocyclyl, CO2-aryl, CO2-heteroaryl, CO2-alkyl-cycloalkyl, CO2-alkyl-heterocyclyl, CO2-alkyl-aryl, CO2-alkyl-heteroaryl, C(O)—NH2, C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl)2, C(O)N(cycloalkyl)2, C(O)N(aryl)2, C(O)N(heteroaryl)2, SO2NH2, SO2NH-alkyl, SO2NH-aryl, SO2NH-heteroaryl, SO2NH-alkyl-aryl, SO2O-alkyl, SO2O-aryl, SO2O-alkyl-aryl, cycloalkyl, heterocyclyl, aryl, and heteroaryl,
wherein the alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl of (ii) optionally include one or more, same or different, substituents selected from the group consisting of
(iii) H, F, Cl, Br, I, CF3, CHF2, CN, NH2, NH-alkyl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, OCHF2, O-alkyl, alkyl, alkyl-O—[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), CH(O), C(O)-alkyl, CO2H, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO3H, SO2-alkyl, SO2NH2, SO2NH-alkyl, and SO2N(alkyl)2,
R3 is NR9R10, wherein R9 is
(iv) hydrogen, alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkyl-cycloalkyl, alkyl-heterocyclyl, alkyl-aryl or alkyl-heteroaryl, wherein the alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl optionally include one or more, same or different, substituents selected from the group consisting of
(v) H, F, Cl, Br, I, CF3, CHF2, CN, NH2, NH-alkyl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, OCHF2, O alkyl, alkyl, alkyl-O—[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), CH(O), C(O)-alkyl, CO2H, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO3H, SO2NH2, SO2NH-alkyl, and SO2N(alkyl)2,
R10 is —C(Y)NR11R12, where Y is O or S, wherein R11 and R12 are independently of one another
(vi) hydrogen,
(vii) unsubstituted or substituted alkyl, where the alkyl radical optionally includes one or more, identical or different, substituents selected from the group consisting of F, Cl, Br, I, CF3, CN, NH2, NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, N(alkyl)2, NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-hetero-aryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO2-alkyl, NHSO2-cycloalkyl, NHSO2-heterocyclyl, NHSO2-aryl, NHSO2-heteroaryl, NHSO2-alkyl-aryl, NHSO2-alkyl-heteroaryl, NO2, SH, S-alkyl, S-cycloalkyl, S-heterocyclyl, S-aryl, S-heteroaryl, OH, OCF3, O-alkyl, O-cycloalkyl, O-heterocyclyl, O-aryl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO3H, OSO2-alkyl, OSO2-cycloalkyl, OSO2-heterocyclyl, OSO2-aryl, OSO2-heteroaryl, OSO2-alkyl-aryl, OSO2-alkyl-heteroaryl, OP(O)(OH)2, C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO2H, CO2-alkyl, CO2-cycloalkyl, CO2-heterocyclyl, CO2-aryl, CO2-heteroaryl, CO2-alkyl-cycloalkyl, CO2-alkyl-heterocyclyl, CO2-alkyl-aryl, CO2-alkyl-heteroaryl, C(O)—NH2, C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl)2, C(O)N(cycloalkyl)2, C(O)N(aryl)2, C(O)N(heteroaryl)2, SO-alkyl, SO-aryl, SO2-alkyl, SO2-aryl, SO2NH2, SO2NH-alkyl, SO2NH-aryl, SO2NH-heteroaryl, SO2NH-alkyl-aryl, SO3H, SO2O-alkyl, SO2O-aryl, SO2O-alkyl-aryl, cycloalkyl, heterocyclyl, aryl, and heteroaryl,
(viii) unsubstituted or substituted cycloalkyl, where the cycloalkyl radical optionally includes one or more, identical or different, substituents selected from the group consisting of F, Cl, Br, I, NH2, NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-aryl, NH-alkyl-heteroaryl, N(alkyl)2, NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO2-alkyl, NHSO2-cycloalkyl, NHSO2-heterocyclyl, NHSO2-aryl, NHSO2-heteroaryl, NHSO2-alkyl-aryl, NHSO2-alkyl-heteroaryl, OH, O-alkyl, O-cycloalkyl, O-heterocyclyl, O-aryl, O-heteroaryl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO3H, OSO2-alkyl, OSO2-cycloalkyl, OSO2-heterocyclyl, OSO2-aryl, OSO2-heteroaryl, OSO2-alkyl-aryl, OSO2-alkyl-heteroaryl, OP(O)(OH)2, CO2H, CO2-alkyl, CO2-cycloalkyl, CO2-heterocyclyl, CO2-aryl, CO2-heteroaryl, CO2-alkylcycloalkyl, CO2-alkyl-hetero-cyclyl, CO2-alkyl-aryl, CO2-alkyl-heteroaryl, C(O)—NH2, C(O)NH-aryl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl)2, C(O)N(cycloalkyl)2, C(O)N(aryl)2, C(O)N(heteroaryl)2, alkyl, and aryl,
(ix) unsubstituted or substituted heterocyclyl, wherein the heterocyclyl radical optionally includes one or more, identical or different, substituents selected from the group consisting of OH, O-alkyl, O-aryl, NH2, NH-alkyl, NH-aryl, alkyl, alkyl-aryl, and aryl,
(x) unsubstituted or substituted aryl, wherein the aryl radical optionally includes one or more, identical or different, substituents selected from the group consisting of F, Cl, Br, I, CF3, CN, NH2, NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, NH-alkyl-NH2, NH-alkyl-OH, N(alkyl)2, NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO2-alkyl, NHSO2-cycloalkyl, NHSO2-heterocyclyl, NHSO2-aryl, NHSO2-heteroaryl, NHSO2-alkyl-aryl, NHSO2-alkyl-heteroaryl, NO2, SH, S-alkyl, S-cycloalkyl, S-heterocyclyl, S-aryl, S-heteroaryl, OH, OCF3, O-alkyl, O-cycloalkyl, O-heterocyclyl, O-aryl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, O-alkyl-OH, O—(CH2)n—O (n=1, 2 or 3), OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO3H, OSO2-alkyl, OSO2-cycloalkyl, OSO2-heterocyclyl, OSO2-aryl, OSO2-heteroaryl, OSO2-alkyl-aryl, OSO2-alkyl-heteroaryl, OP(O)(OH)2, C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO2H, CO2-alkyl, CO2-cycloalkyl, CO2-heterocyclyl, CO2-aryl, CO2-heteroaryl, CO2-alkyl-cycloalkyl, CO2-alkyl-heterocyclyl, CO2-alkyl-aryl, CO2-alkyl-heteroaryl, C(O)—NH2, C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl)2, C(O)N(cycloalkyl)2, C(O)N(aryl)2, C(O)N(heteroaryl)2, SO-alkyl, SO-aryl, SO2-alkyl, SO2-aryl, SO2NH2, SO2NH-alkyl, SO2NH-aryl, SO2NH-heteroaryl, SO2NH-alkyl-aryl, SO3H, SO2O-alkyl, SO2O-aryl, SO2O-alkylaryl, alkyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl,
(xi) unsubstituted or substituted heteroaryl, wherein the heteroaryl radical optionally includes one or more, identical or different, substituents selected from the group consisting of F, Cl, Br, I, CF3, CN, NH2, NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, NH-alkyl-NH2, NH-alkyl-OH, N(alkyl)2, NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO2-alkyl, NHSO2-cycloalkyl, NHSO2-heterocyclyl, NHSO2-aryl, NHSO2-heteroaryl, NHSO2-alkyl-aryl, NHSO2-alkyl-heteroaryl, NO2, SH, S-alkyl, S-aryl, S-heteroaryl, OH, OCF3, O-alkyl, O-cycloalkyl, O-aryl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO3H, OSO2-alkyl, OSO2-cycloalkyl, OSO2-heterocyclyl, OSO2-aryl, OSO2-heteroaryl, OSO2-alkyl-aryl, OSO2-alkyl-heteroaryl, OP(O)(OH)2, C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO2H, CO2-alkyl, CO2-cycloalkyl, CO2-heterocyclyl, CO2-aryl, CO2-heteroaryl, CO2-alkyl-cycloalkyl, CO2-alkyl-heterocyclyl, CO2-alkyl-aryl, CO2-alkyl-heteroaryl, C(O)—NH2, C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl)2, C(O)N(cycloalkyl)2, C(O)N(aryl)2, C(O)N(heteroaryl)2, SO2NH2, SO2NH-alkyl, SO2NH-aryl, SO2NH-heteroaryl, SO2NH-alkyl-aryl, SO3H, SO2O-alkyl, SO2O-aryl, SO2O-alkyl-aryl, alkyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl,
(xii) —C(O)—R17, wherein R17 is alkyl, aryl or heteroaryl, and wherein alkyl and aryl optionally include one or more, same or different, substituents selected from the group consisting of F, Cl, Br, I, CN, CF3, NH2, NH-alkyl, NH-aryl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, O-alkyl, O-aryl, OSO3H, OP(O)(OH)2, CHO, CO2H, SO3H, and alkyl,
(xiii) or R11 and R12 together form a cycloalkyl or heterocyclyl.

### Claim 66 (depends on 65)

The pyrido[2,3-b]pyrazine compound according to claim 65, wherein R1 is selected from the group consisting of
(i) pyrrolyl, furyl, thienyl, thiazolyl, oxazolyl, isoxazolyl, pyrazolyl, imidazolyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, phthalazinyl, indolyl, indazolyl, indolizinyl, quinolinyl, isoquinolinyl, quinoxalinyl, quinazolinyl, carbazolyl, phenazinyl, phenothiazinyl, and acridinyl,
wherein the heteroaryl radicals in (i) are substituted with one radical selected from the group consisting of
(ii) C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, SO2NH-alkyl, SO2NH-aryl, SO2NH-heteroaryl, SO2NH-alkyl-aryl, SO2O-alkyl, SO2O-aryl, SO2O-alkyl-aryl, alkyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl,
wherein the alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl radicals in (ii) optionally include one or more, same or different, substituents selected from the group consisting of
(iii) NH-alkyl, N(alkyl)2, S-alkyl, O-alkyl, alkyl, alkyl-OH, alkyl-NH2, alkyl-SH, alkyl-O-alkyl, alkyl-O—[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH-alkyl, alkyl-N-(alkyl)2, alkyl-5-alkyl, C(O)-alkyl, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO2-alkyl, SO2NH-alkyl, SO2N(alkyl)2, alkyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl,
and wherein the alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl in (iii) optionally include one or more, same or different, substituents selected from the group consisting of
(iv) H, F, Cl, Br, I, CF3, CHF2, CN, NH2, NH-alkyl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, OCHF2, O-alkyl, alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-O-[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH2, alkyl-NH-alkyl, alkyl-N(alkyl)2, CH(O), C(O)-alkyl, CO2H, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO3H, SO2-alkyl, SO2NH2, SO2NH-alkyl, and SO2N(alkyl)2,
R3 is NHC(O)NH-alkyl or NHC(S)NH-alkyl, wherein the alkyl radical is selected from the group consisting of
(v) methyl, ethyl, n-propyl, 2-propyl, n-butyl, sec-butyl, tert-butyl, n-pentyl, iso-pentyl, neo-pentyl, n-hexyl, 2-hexyl, n-heptyl, n-octyl, ethylenyl (vinyl), ethynyl, propenyl (—CH2CH═CH2, —CH═CH—CH3, —C(═CH2)—CH3), propynyl (—CH2—C≡CH, —C≡C—CH3), butenyl, butynyl, pentenyl, pentynyl, hexenyl, hexynyl, heptenyl, heptynyl, octenyl, octynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl, and where the alkyl radials in (v) optionally include one or more, same or different, substituents selected from the group consisting of
(vii) F, Cl, Br, I, CF3, CHF2, CN, NH2, NH-alkyl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, OCHF2, O-alkyl, alkyl, alkyl-OH, alkyl-O—[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH2, alkyl-NH-alkyl, alkyl-N(alkyl)2, CH(O), C(O)-alkyl, CO2H, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO3H, SO2-alkyl, SO2NH2, SO2NH-alkyl, and SO2N(alkyl)2.

### Claim 67 (depends on 65)

The pyrido[2,3-b]pyrazine compound according to claim 65, wherein R1 is pyrazolyl substituted with one or more alkyl-aryl substituents, wherein the alkyl-aryl radical optionally include one or more, same or different, substituents selected from the group consisting of
(i) H, F, Cl, Br, I, CF3, CHF2, CN, NH2, NH-alkyl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, OCHF2, O-alkyl, alkyl, alkyl-OH, alkyl-O—[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH2, alkyl-NH-alkyl, alkyl-N(alkyl)2, CH(O), C(O)-alkyl, CO2H, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO3H, SO2-alkyl, SO2NH2, SO2NH-alkyl, and SO2N(alkyl)2,
R3 is NHC(O)NH-alkyl or NHC(S)NH-alkyl, wherein the alkyl radical is selected from the group consisting of
(ii) methyl, ethyl, n-propyl, 2-propyl, n-butyl, sec-butyl, ethylenyl (vinyl), ethynyl, propenyl (—CH2CH═CH2, —CH═CH—CH3, —C(═CH2)—CH3), propynyl (—CH2—C≡CH, —C≡C—CH3), butenyl, butynyl, cyclopropyl, and cyclobutyl,
and wherein the alkyl radials in (ii) optionally include one or more, same or different, substituents selected from the group consisting of
(iii) F, Cl, Br, I, CF3, CHF2, CN, NH2, NH-alkyl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, OCHF2, O-alkyl, alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-O—[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH2, alkyl-NH-alkyl, alkyl-N(alkyl)2, CH(O), C(O)-alkyl, CO2H, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO3H, SO2-alkyl, SO2NH2, SO2NH-alkyl, and SO2N(alkyl)2.

### Claim 68 (depends on 65)

The pyrido[2,3-b]pyrazine compound according to claim 65, wherein R1 is (1-benzyl)pyrazol-4-yl, optionally substituted with or more, same or different, substituents selected from the group consisting of
(i) F, Cl, Br, I, CF3, CHF2, CN, NH2, NH-alkyl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, OCHF2, O-alkyl, alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-O—[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH2, alkyl-NH-alkyl, alkyl-N(alkyl)2, CH(O), C(O)-alkyl, CO2H, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO3H, SO2NH2, SO2NH-alkyl, and SO2N(alkyl)2,
R3 is NHC(O)NH-alkyl or NHC(S)NH-alkyl, wherein the alkyl radical is selected from the group consisting of
(i) methyl, ethyl, n-propyl, 2-propyl, n-butyl, sec-butyl, ethylenyl (vinyl), ethynyl, propenyl (—CH2CH═CH2, —CH═CH—CH3, —C(═CH2)—CH3), propynyl (—CH2—C≡CH, —C≡C—CH3), cyclopropyl, and cyclobutyl,
and wherein the alkyl radicals in (i) optionally include one or more, same or different, substituents selected from the group consisting of
(ii) F, Cl, Br, I, CF3, CHF2, CN, NH2, NH-alkyl, N(alkyl)2, NO2, SH, S-alkyl, OH, OCF3, OCHF2, O-alkyl, alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-O—[(CH2)n—O]m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH2, alkyl-NH-alkyl, alkyl-N(alkyl)2, CH(O), C(O)-alkyl, CO2H, CO2-alkyl, C(O)—NH2, C(O)NH-alkyl, C(O)N(alkyl)2, SO3H, SO2NH2, SO2NH-alkyl, and SO2N(alkyl)2.

### Claim 69 (depends on 65)

A pharmaceutical composition comprising a pharmacologically active amount of at least one compound according to claim 65.

### Claim 70 (depends on 69)

The pharmaceutical composition according to claim 69, where the at least one compound is present in a unit dose of from 0.001 mg to 100 mg per kg of a patient's bodyweight.

### Claim 71 (depends on 69)

The pharmaceutical composition according to claim 69, further comprising at least one pharmaceutically acceptable carrier and/or excipient.
